DAVID HUFFMAN: Open Payments
NPI 1063860526 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$23,399 in 265 payments from 16 companies in 2025. Trend: 2023 $13,261 · 2024 $11,075 · 2025 $23,399
Speaker / faculty: $18,300Food & beverage: $4,429Travel & lodging: $648Education: $22
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 100 | $20,147 |
| Vanda Pharmaceuticals Inc. | 28 | $662 |
| E.R. Squibb & Sons, L.L.C. | 26 | $509 |
| Lundbeck LLC | 15 | $342 |
| Neurocrine BioSciences, Inc. | 15 | $319 |
| Otsuka America Pharmaceutical, Inc. | 13 | $286 |
| Axsome Therapeutics, Inc. | 13 | $215 |
| Alkermes, Inc. | 15 | $198 |
| Janssen Pharmaceuticals, Inc | 9 | $185 |
| Supernus Pharmaceuticals, Inc. | 12 | $172 |
Products named: VRAYLAR, COBENFY, HETLIOZ, INGREZZA, REXULTI, ABILIFY MAINTENA, FANAPT, Auvelity.
Industry payments across OH — which companies pay providers there.
